-
-
Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs) in the elderly may increase the risk of dementia and Alzheimer's disease according to a new study.
-
Perform a Google search of "low-dose naltrexone" and you will find a myriad of anecdotal testimonies to the benefits of the drug in a wide range of diseases including fibromyalgia. Now a small study suggests that naltrexone may be of some benefit in this difficult condition.
-
For patients with glucocorticoid-induced osteoporosis, a once-yearly infusion of zoledronic acid is as effective as daily risedronate for the prevention and treatment of bone loss according to a new study from Lancet.
-
Plan B, the so-called "morning after pill" will soon be available to women age 17 and older without a prescription.
-
-
The Canadian Association of Gastroenterology Consensus Group has published guidelines on use of long-term NSAIDs in patients at risk for GI bleeding and cardiovascular disease.
-
Median survival for patients with metastatic colorectal cancer has nearly doubled over the past 15 years with the introduction of several new drugs, including monoclonal antibodies. The increments in survival, however, have been relatively modest when placed in the context of the costs of therapy. Using a Markhov model on a hypothetical cohort of 1,000 patients, the incremental cost-effectiveness ratio per documented life-year was greater than $170,000, well beyond the usual standards for cost effectiveness.
-
Age and HER2 status were shown to independently affect MRI accuracy in defining residual disease after neo-adjuvant systemic therapy for locally advanced breast cancer
-
The combination of capecitabine and oxaliplatin administered concurrently with radiation therapy as preoperative treatment for rectal cancer proves highly effective in producing complete or near-complete pathologically determined responses, and with excellent tolerability.
